menu
    • menu

    Company profile for i2o Therapeutics

    NEW Drugs in Dev: 2
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    i2o Therapeutics is a biotech company developing safe and effective oral formulations of therapies traditionally limited to injections. Using an innovative ionic liquid technology, this platform leverages the benefits of protecting the drug cargo while also transiently enhancing permeation across the epithelial lining when administered orally. i2o is focused on creating the next generation of oral peptide and protein-based the...
    i2o Therapeutics is a biotech company developing safe and effective oral formulations of therapies traditionally limited to injections. Using an innovative ionic liquid technology, this platform leverages the benefits of protecting the drug cargo while also transiently enhancing permeation across the epithelial lining when administered orally. i2o is focused on creating the next generation of oral peptide and protein-based therapies. Boston-based biotech startup developing novel biologic therapies that can be administered orally.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    i2o TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    127 Western Ave Allston, MA 02134
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://i2obio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    US FDA panel votes against diabetes implant due to safety concerns
    US FDA panel votes against diabetes implant due to safety concerns

    22 Sep 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-votes-against-diabetes-implant-due-safety-concerns-2023-09-21/

    REUTERS
    22 Sep 2023
    Share Share
    i2o Therapeutics Names Kurt Graves Chairman and CEO, Announces Corporate Updates
    i2o Therapeutics Names Kurt Graves Chairman and CEO, Announces Corporate Updates

    28 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230828112025/en

    BUSINESSWIRE
    28 Aug 2023
    Share Share
    i2O Therapeutics Announces Research Collaboration, Option Agreement with Janssen
    i2O Therapeutics Announces Research Collaboration, Option Agreement with Janssen

    06 Jan 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220106005126/en

    BUSINESSWIRE
    06 Jan 2022
    Share Share
    i2O Therapeutics Announces Research Collaboration with Sanofi to Enable Oral
    i2O Therapeutics Announces Research Collaboration with Sanofi to Enable Oral

    10 Feb 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210210005203/en

    BUSINESSWIRE
    10 Feb 2021
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search